300244200076

The barcode 300244200076 corresponds to Uroxatral Extended-Release Tablets, a medication manufactured by Bayer Corporation/Consumer Care Division. Uroxatral, containing the active ingredient alfuzosin, is primarily used to alleviate symptoms of benign prostatic hyperplasia (BPH) in men, which is a condition characterized by an enlarged prostate.

Key Information about Uroxatral Extended-Release Tablets:

• Formulation: Extended-release tablets
• Dosage: Available in 10mg and 20mg strengths, typically prescribed to be taken once daily.
• Classification: Prescription medication, indicating that it should be obtained through a healthcare provider's prescription.

Health Concerns and Side Effects:

Uroxatral is associated with several potential health-related issues, including:

1. Postural Hypotension: Users may experience a significant drop in blood pressure when standing up, leading to dizziness or fainting.
2. Priapism Risk: As an alpha-blocker, there is an increased risk of priapism, a condition where erections can become prolonged and painful, necessitating immediate medical intervention.
3. Allergic Reactions: Some patients may have allergic responses, which can include symptoms like hives, itching, or breathing difficulties.

Price Information:

The wholesale price for a 30-tablet supply of Uroxatral is estimated to range between $100 to $150 USD, depending on the dosage (10mg or 20mg). Retail prices may vary based on pharmacy location and stock.

General Health-Related Disclaimers:

While there are no barcode-specific warnings for Uroxatral, general consumption-related disclaimers may be present on its packaging, such as:

• "Use as directed by your doctor."
• "Do not take more than prescribed by your doctor."
• "If you experience any side effects, contact your doctor or pharmacist immediately."

It is crucial for patients to adhere to prescribed dosages and to consult healthcare professionals regarding any side effects or health concerns related to the use of Uroxatral Extended-Release Tablets.